Insights on Hatch-Waxman Litigation

Bradford Frese will present at the 13th Annual Pharma IPR India Conference on March 5, 2024.

Kevin Nelson will speak at the American Conference Institute’s 9th Annual Paragraph IV Disputes Master Symposium on October 25, 2023.

ArentFox Schiff is proud to announce that the firm has been recognized as “Firm of the Year – Hatch-Waxman Litigation” at the LMG Life Sciences Americas Awards 2023.

ArentFox Schiff is pleased to announce that 130 attorneys have been recognized by The Best Lawyers in America 2024, with an additional four attorneys highlighted as “Lawyers of the Year” and 69 attorneys listed as “Ones to Watch.”

“Why Aren’t There More Patent Cases Pending, Considering the Size of the Biosimilar Pipeline?”

Partner Kevin Nelson shared his insight on the current state of biosimilar patent litigation and regulatory proceedings, and new challenges facing drug manufacturers in bringing biosimilar products to market.

ArentFox Schiff is pleased to sponsor ACI’s 18th Annual Paragraph IV Disputes Conference with Kevin Nelson presenting on April 20, 2023.

Richard Berman and Bradford Frese will present at the Annual US PARA-IV & Global IP Litigation Symposium on March 3 and 4, 2023

Janine Carlan will co-panel a discussion on “Key Focus on Winning Patent Litigation Strategies,” on March 2, 2023 at 10 AM, IST

ArentFox Schiff is pleased to announce that the firm and two partners have been shortlisted for the annual Managing IP Americas Awards.

Helen Ji will moderate a table at the Chicago Women in IP Annual Progressive Networking Dinner on February 8, 2023.

ArentFox Schiff is pleased to announce that five attorneys have been ranked by LMG Life Sciences, which recognizes the work of outstanding individuals in the life sciences sector.

ArentFox Schiff is pleased to announce that the firm and two partners have been shortlisted for the annual LMG Life Sciences Americas Awards.

ArentFox Schiff is proud to announce that the firm and three of its attorneys have been ranked in the 2022 edition of IAM Patent 1000: The World’s Leading Patent Professionals, a guide that identifies top patent professionals based on interviews with private practice and in-house professionals.

ArentFox Schiff is pleased to announce that the firm has again been ranked by Managing Intellectual Property magazine as IP Stars.

ArentFox Schiff is sponsoring the ACI Paragraph IV Disputes Conference and Rich Berman and Sal Patel will present.

Partner Kevin Nelson was quoted on a Federal Circuit Court ruling in GlaxoSmithKline v. Teva, which has caused concern among some generic drug manufacturers regarding their ability to sell generic drugs that leave patent-protected uses off the label.

Schiff Hardin has been ranked “Recommended” by LMG Life Sciences in the Hatch-Waxman Patent Litigation (Generic) category of its 2021 guide.

Partner Imron Aly was quoted regarding a letter from the U.S. Food and Drug Administration (FDA) sent to the U.S. Patent and Trademark Office (USPTO) with suggestions on how to prevent some patent-owning pharmaceutical companies from blocking generics from entering the market.

IPR Connexion

IPR Connexion

Intellectual Property Practice Group Co-Leader Imron Aly was quoted on the recent U.S. Supreme Court ruling in Minerva v. Hologic. The decision modified and limited the previous bar on inventors from challenging the validity of their patents after they have been assigned to others.

Schiff Hardin LLP is proud to announce that the firm and four of its attorneys have been ranked in the 2021 edition of IAM Patent 1000: The World’s Leading Patent Professionals, a guide that identifies top patent professionals based on 1,800 interviews with private practice and in-house professionals.

Modern Healthcare

The Center for Biosimilars